Furthermore, complement inhibition at the level of C3 (with a CR2-Crry fusion protein) in combination with radiation has been demonstrated to enhance the numbers of macrophages with an M1-like phenotype (F4/80+, CD11c+, CD206-) in lymphoma tumor models (35). The gene discussed is C3; the disease is neoplasm.